Demyelination in the central nervous system mediated by an anti- oligodendrocyte antibody

Journal of Neuroscience Research

Volumn 54, Issue 2, 1998, Pages 158-168

  Zhou, Lixin ^a,b   Trapp, Bruce D ^a,b   Miller, Robert H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autoantibody; Multiple sclerosis; Myelin; Oligodendrocyte; Optic nerve

Indexed keywords

AUTOANTIBODY;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; DEMYELINATION; FEMALE; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NONHUMAN; OPTIC NERVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASES; CEREBRAL VENTRICLES; DEMYELINATING DISEASES; FEMALE; HYBRIDOMAS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION IMMUNOLOGY;

EID: 0032532333     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981015)54:2<158::AID-JNR4>3.0.CO;2-D     Document Type: Article

References (34)

1. Abramsky O, Lisak RP, Silberberg DH, Pleasure D (1977): Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med 297:1207-1211.
2. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois DM (1992): Pre-oligodendrocytes from adult human CNS. J Neurosci 12: 1538-1547.
3. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC (1992): Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
4. Bedi KS, Warren MA (1983): The effects of undernutrition during early life on the rat optic nerve fibre number and size-frequency distribution. J Comp Neurol 219:125-132.
5. Bernard CC, de Rosbo Nk (1991): Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol Napoli 13:171-178.
6. Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM (1977): Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. J Immunol 118:2103-2110.
7. Carroll WM, Jennings AR, Mastaglia FL (1985): Galactocerebroside antiserum causes demyelination of cat optic nerve. Brain Res 330:378-381.
8. Forrester J, Peters A (1967): Nerve fibres in optic nerve of rat. Nature 214:245-247.
9. Fujita N, Sato S, Ishiguro H, Inuzuka T, Baba H, Kurihara T, Takahashi Y, Miyatake T (1990): The large isoform of myelin-associated glycoprotein is scarcely expressed in the quaking mouse brain. J Neurochem 55:1056-1059.
10. Glynn P, Linington C (1989): Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system. Crit Rev Neurobiol 4:367-385.
11. Hunter SF, Rodriguez M (1995): Multiple sclerosis: a unique immunopathological syndrome of the central nervous system. Springer Semin Immunopathol 17:89-105.
12. Kerlero dRN, Bernard CCA (1989): Multiple sclerosis: Brain immunoglobulins stimulate myelin basic protein degradation in human myelin: A new cause of demyelination. J Neurochem 53:513-518.
13. Lemmon V, McLoon SC (1986): The appearance of an L1-like molecule in the chick primary visual pathway. J Neurosci 6:2987-2994.
14. Lowe J, Cox G (1990): Neuropathological techniques. In Stevens BJD, Stevens A (eds): "Theory and Practice of Histological Techniques." New York: Churchill Livingstone, pp 356-358.
15. Ng AY, Stone J (1982): The optic nerve of the cat: Appearance and loss of axons during normal development. Brain Res 281:263-271.
16. Pedersen JS, Walker M, Toh BH, De AH, Lolait SJ, Bernard CC (1983): Flow microfluorometry detects IgM autoantibody to oligodendrocytes in multiple sclerosis. J Neuroimmunol 5:251-259.
17. Pfeiffer S, Warrington A, Bansal R (1993): The oligodendrocyte and its many processes. Trends Cell Biol 3:191-197.
18. Piddlesden SJ, Lassmann H, Zimprich F, Morgan BP, Linington C (1993): The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143:555-564.
19. Prineas JW (1985): The neuropathology of multiple sclerosis. Handb Clin Neurol 47:213-257.
20. Raine CS (1984): Biology of disease. The analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab Invest 50:608-635.
21. Rosenbluth J, Liu Z, Guo D, Schiff R (1994): Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells. J Neurocytol 23:699-707.
22. Schluesener HJ, Sobel RA, Linington C, Weiner HL (1987): A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139:4016-4021.
23. Schnell L, Schwab ME (1990): Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343:269-272.
24. Scolding NJ, Rayner PJ, Sussman J, Shaw C, Compston DAS (1995): A proliferative adult human oligodendrocyte progenitor. NeuroReport 6:441-445.
25. Seil FJ, Westall FC, Romine JS, Salk J (1983): Serum demyelinating factors in multiple sclerosis. Ann Neurol 13:664-667.
26. Sternberger LA, Sternberger NH (1983): Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci USA 80:6126-6130.
27. Streit WJ, Kreutzberg GW (1987): Lectin binding by resting and reactive microglia. J Neurocytol 16:249-260.
28. Trapp BD, Nishiyama A, Cheng D, Macklin W (1997): Differentiation and death of premyelinating oligodendrocytes in developing rodent brain. J Cell Biol 137:459-468.
29. Ulrich J, Lardi H (1978): Multiple sclerosis: Demyelination and myelination inhibition of organotypic tissue cultures of the spinal cord by sera of patients with multiple sclerosis and other neurological diseases. J Neurol 218:7-16.
30. Waxman SG (1977): Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch Neurol 34:585-589.
31. Weibel ER (1979): Practical methods for biological morphometry. In "Stereological Methods." Weibel ER (ed): London: Academic Press pp. 380-396.
32. Wolswijk G, Noble M (1989): Identification of an adult-specific glial progenitor cell. Development 105:387-400.
33. Zhou L, Miller RH (1998): Antibody-mediated oligodendrocyte cell death requires an astrocyte-derived co-signal. J Neurosci Res 52:137-148.
34. Zhou L, Szigeti V, Miller RH (1995): Characterization of a novel oligodendrocyte cell surface molecule. J Neurosci Res 42:504-515.